Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Horien Biochemical Technology Co., Ltd. (7814:TWSE), powered by AI.
Horien Biochemical Technology Co., Ltd. is currently trading at $35.40. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Horien Biochemical Technology Co., Ltd. on Alpha Lenz.
View Horien Biochemical Technology Co., Ltd.'s valuation metrics on Alpha Lenz.
“Horien Biochemical Technology Co., Ltd.'s ROE is -1.7%. Explore profitability and growth together.”
Ask for details →Horien Biochemical Technology Co., Ltd. is a leading manufacturer in the health care equipment sector, specializing in the development and production of collagen-based medical devices and cosmetic raw materials. Founded in 2006 and headquartered in Taichung, Taiwan, the company focuses on innovative solutions for regenerative medicine, dental surgery, medical beauty, ophthalmology, and general surgical applications. Its product portfolio encompasses dental wound protection materials, collagen dental matrices, collagen regeneration films, bone fillers, bioink, and artificial bone substitutes, serving both medical and cosmetic industries. Horien’s advanced R&D centers feature state-of-the-art laboratories and clean rooms, delivering high-quality, safe, and effective products that are exported to markets including Europe, the USA, and China. The firm’s commitment to research and collaboration with international experts underscores its significant role in advancing medical technology and regenerative healthcare solutions in Taiwan and globally.
“Horien Biochemical Technology Co., Ltd.'s ROE is -1.7%. Explore profitability and growth together.”
Ask for details →Horien Biochemical Technology Co., Ltd. (ticker: 7814) is a company listed on TWSE in the Healthcare sector (Biotechnology).
The current price is 35.4 with a P/E ratio of -x and P/B of -x.
ROE is -1.69% and operating margin is -9.82%. Annual revenue is $83M.